A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Immunology Bookmark and Share

Immunology

City of Hope’s Department of Immunology, one ofeight major basic science (“Laboratory Research”) departments of the Beckman Research Institute, was established in 1972 by Charles Todd. At that time, immune-based therapies were used on a very limited basis in cancer treatment, reserved for conditions such as malignant melanoma and bladder cancer. Most immunotherapy treatments consisted of agents such as BCG and interferon.

In recent years, the field of cancer immunology has grown by leaps and bounds, and a wide range of neoplastic diseases, including both hematologic malignancies and solid tumors,are routinely being treated with a well-stocked armamentarium of monoclonal antibodies and other immunotherapy methods.

The Department of Immunology continues its original vision, with a dual focus on both immunology and structural biology. It has seven principal investigators with research interests in cell and tumor immunology and structure analysis, who are aided by state-of-the-art facilities in mass spectrometry and NMR, as well as a computer cluster for computational chemistry.

The unique combination of biological and structural studies and the intensive exploration of structure-function relationships have created a thriving, productive environment that has encouraged fruitful collaboration among investigators at City of Hope and at other institutions.
 
Laboratory Research

John Shively, Ph.D. -  CEA (carcinoembryonic antigen) gene family
Dr. Shively's lab specializes in the CEA (carcinoembryonic antigen) gene family. In particular, he is researching the use of anti-CEA antibodies for tumor imaging and therapy and the role of CEACAM1 in T-cell activation and mammary epithelial cell polarization.  He is also exploring the relationship of the immune system and genetics to fibromyalgia.
 
Terry Lee, Ph.D. - Optimizing the application of biomolecule mass spectrometry
Dr. Lee’s focus is optimizing the application of biomolecule mass spectrometry to “real-world” biological problems. He develops new methods for proteomic analyses by mass spectrometry including integrated microfluidic systems for sample preparation and automated methods of data acquisition and analysis.
 
Markus Kalkum, Ph.D. - Develops novel biochemical and mass spectrometric methods
Dr. Kalkum develops novel biochemical and mass spectrometric methods for the sensitive detection of functional biomolecules in complex samples. His goal is to improve the early diagnosis of emerging and frequently under-diagnosed diseases, including opportunistic fungal and bacterial infections common in transplant recipients.
 
Nagarajan Vaidehi, Ph.D. - Devises computational approaches
Dr. Vaidehi devises computational approaches to study the structure, function and dynamics of G-protein coupled receptors. Of particular interest is the interaction of chemokines, and antagonists to the chemokine receptors, that trigger leukocyte migration in immune response and inflammation. By predicting binding-site interactions of agonists and antagonists with the receptors, the drug development process is greatly streamlined.
 
Zuoming Sun, Ph.D. - Studies the mechanisms controlling T-cell activation and survival
Dr. Sun’s lab studies the mechanisms controlling T-cell activation and survival. Activation and survival of T-lymphocytes control the quality and magnitude of immune response. Manipulation of T-cell activity is therefore one of the most important treatments for 1) enhancing immune responses against pathogens and tumors and 2) inhibiting the immune responses involved in autoimmune diseases and transplant rejection.
 

Immunology Faculty

Immunology

Immunology

City of Hope’s Department of Immunology, one ofeight major basic science (“Laboratory Research”) departments of the Beckman Research Institute, was established in 1972 by Charles Todd. At that time, immune-based therapies were used on a very limited basis in cancer treatment, reserved for conditions such as malignant melanoma and bladder cancer. Most immunotherapy treatments consisted of agents such as BCG and interferon.

In recent years, the field of cancer immunology has grown by leaps and bounds, and a wide range of neoplastic diseases, including both hematologic malignancies and solid tumors,are routinely being treated with a well-stocked armamentarium of monoclonal antibodies and other immunotherapy methods.

The Department of Immunology continues its original vision, with a dual focus on both immunology and structural biology. It has seven principal investigators with research interests in cell and tumor immunology and structure analysis, who are aided by state-of-the-art facilities in mass spectrometry and NMR, as well as a computer cluster for computational chemistry.

The unique combination of biological and structural studies and the intensive exploration of structure-function relationships have created a thriving, productive environment that has encouraged fruitful collaboration among investigators at City of Hope and at other institutions.
 
Laboratory Research

John Shively, Ph.D. -  CEA (carcinoembryonic antigen) gene family
Dr. Shively's lab specializes in the CEA (carcinoembryonic antigen) gene family. In particular, he is researching the use of anti-CEA antibodies for tumor imaging and therapy and the role of CEACAM1 in T-cell activation and mammary epithelial cell polarization.  He is also exploring the relationship of the immune system and genetics to fibromyalgia.
 
Terry Lee, Ph.D. - Optimizing the application of biomolecule mass spectrometry
Dr. Lee’s focus is optimizing the application of biomolecule mass spectrometry to “real-world” biological problems. He develops new methods for proteomic analyses by mass spectrometry including integrated microfluidic systems for sample preparation and automated methods of data acquisition and analysis.
 
Markus Kalkum, Ph.D. - Develops novel biochemical and mass spectrometric methods
Dr. Kalkum develops novel biochemical and mass spectrometric methods for the sensitive detection of functional biomolecules in complex samples. His goal is to improve the early diagnosis of emerging and frequently under-diagnosed diseases, including opportunistic fungal and bacterial infections common in transplant recipients.
 
Nagarajan Vaidehi, Ph.D. - Devises computational approaches
Dr. Vaidehi devises computational approaches to study the structure, function and dynamics of G-protein coupled receptors. Of particular interest is the interaction of chemokines, and antagonists to the chemokine receptors, that trigger leukocyte migration in immune response and inflammation. By predicting binding-site interactions of agonists and antagonists with the receptors, the drug development process is greatly streamlined.
 
Zuoming Sun, Ph.D. - Studies the mechanisms controlling T-cell activation and survival
Dr. Sun’s lab studies the mechanisms controlling T-cell activation and survival. Activation and survival of T-lymphocytes control the quality and magnitude of immune response. Manipulation of T-cell activity is therefore one of the most important treatments for 1) enhancing immune responses against pathogens and tumors and 2) inhibiting the immune responses involved in autoimmune diseases and transplant rejection.
 

Immunology Faculty

Immunology Faculty

Overview
Beckman Research Institute of City of Hope is responsible for fundamentally expanding the world’s understanding of how biology affects diseases such as cancer, HIV/AIDS and diabetes.
 
 
Research Departments/Divisions

City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.
 

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 


NEWS & UPDATES
  • White button mushrooms seem fairly innocuous as fungi go. Unlike portabellas, they don’t center stage at the dinner table, and unlike truffles, they’re not the subject of gourmand fervor. But appearances can be deceiving when it comes to these mild-mannered Clark Kents of the food world. In a study ...
  • Doctors often recommend preventive screenings for several cancers, based on hereditary or genetic factors, but brain tumors aren’t one of them. Primary brain tumors, which originate in the brain rather than spreading from another location, seem to develop at random, and doctors have little insight into wh...
  • Stopping cancer starts with research. To that end, STOP CANCER has awarded $525,000 in grants to City of Hope for 2015, supporting innovative research projects and recognizing the institution’s leadership in advancing cancer treatment and prevention. Founded in 1988, STOP CANCER underwrites the work of le...
  • Cancer may not be the disease many people think it is. Normally, cancer is considered to be a disease in which cells multiply at an extremely high, and unusual, rate – increasing the likelihood of genetic mutations. But increasingly, leading researchers at City of Hope and elsewhere are contending that cancer i...
  • “Of all forms of inequality, injustice in the health care system is the most shocking and inhumane.” By the time the Rev. Martin Luther King Jr. spoke those words in Chicago in 1966, the Civil Rights Act had been passed, the Voting Rights Act was the law of the land and the March on Washington was […]
  • Eight years ago, Matthew Loscalzo surprised himself by accepting the offer to become City of Hope’s administrative director of the Sheri & Les Biller Patient and Family Resource Center and executive director of the Department of Supportive Care Medicine. At the time, he was administrative director of the Sc...
  • The mental fog that patients can experience after undergoing chemotherapy treatment for cancer has a name: “chemo brain.” “Many patients report hearing or reading about chemotherapy-related cognitive deficits, but few are actually prepared to deal with these changes,” said Celina Lemon, M.A., an occupational th...
  • Cancer treatments have improved over the years, but one potential source of treatments and cures remains largely untapped: nature. Blueberries, cinnamon, xinfeng, grape seed (and skin) extract, mushrooms, barberry and pomegranates all contain compounds with the potential to treat or prevent cancer. Scientists a...
  • In the U.S., there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate and lung, according to the American Cancer Society. Each year, 5 million people are treated for skin cancer. Here, Hans Schoellhammer, M.D., assistant clinical professor at City of Hope | Ant...
  • As public health experts know, health improvement starts in the community. Now, City of Hope  has been recognized for its efforts to improve the lives of residents of its own community. The institution will receive funding from the Institute for Healthcare Improvement  to support promising community-based work ...
  • For almost four decades, blood cancer survivors who received bone marrow, or stem cell, transplants have returned to City of Hope to celebrate life, second chances and science. The first reunion, in 1976, was a small affair: spaghetti for a single patient, his brother who served as his donor and those who took ...
  • Chemotherapy is an often-essential component of cancer treatment, attacking cells that divide quickly and helping stop cancer’s advance. But the very characteristics that make chemotherapy effective against cancer also can make it toxic to healthy cells, leading to side effects such as hair loss, nausea, ...
  • When you want to understand how to enhance the patient experience, go straight to the source: The patients. Patients and their families offer unique perspectives on care and services and can provide valuable insights about what is working well and what is not. That’s why City of Hope turns to them for advice. S...
  • Take it from City of Hope researchers: Medical science isn’t just for scientists, but something the whole family can enjoy. From 1 to 4 p.m. on Saturday, May 16, the institution will offer a variety of educational and fun-filled science and healthy living activities at its second Community Science Festiva...
  • Attention, parents! Only a few serious sunburns can increase a child’s ultimate risk of skin cancer. Further, some studies suggest that ultraviolet (UV) exposure before the age of 10 is the most important factor for melanoma risk. Here skin cancer expert Jae Jung, M.D., Ph.D., assistant professor in the D...